EMA publishes new plan to support antibiotic development

Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Photo: Peter Dejong/AP/Ritzau Scanpix
Photo: Peter Dejong/AP/Ritzau Scanpix
by christian bundgaard, translated by daniel pedersen

The European Medicines Agency (EMA) has a plan to address the increasingly pressing challenge of antibiotic-resistant bacteria, the EMA reports in a news release on its website.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading